Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ensysce Biosciences (ENSCW) Assets Average (2020 - 2025)

Historic Assets Average for Ensysce Biosciences (ENSCW) over the last 6 years, with Q3 2025 value amounting to $4.4 million.

  • Ensysce Biosciences' Assets Average fell 2813.08% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 2813.08%. This contributed to the annual value of $4.2 million for FY2024, which is 334.94% down from last year.
  • Ensysce Biosciences' Assets Average amounted to $4.4 million in Q3 2025, which was down 2813.08% from $5.1 million recorded in Q2 2025.
  • Ensysce Biosciences' 5-year Assets Average high stood at $14.4 million for Q1 2022, and its period low was $3.0 million during Q4 2023.
  • For the 5-year period, Ensysce Biosciences' Assets Average averaged around $7.6 million, with its median value being $7.1 million (2022).
  • In the last 5 years, Ensysce Biosciences' Assets Average plummeted by 6595.93% in 2023 and then skyrocketed by 15278.45% in 2024.
  • Quarter analysis of 5 years shows Ensysce Biosciences' Assets Average stood at $13.1 million in 2021, then crashed by 45.76% to $7.1 million in 2022, then crashed by 58.19% to $3.0 million in 2023, then skyrocketed by 152.78% to $7.5 million in 2024, then crashed by 41.57% to $4.4 million in 2025.
  • Its last three reported values are $4.4 million in Q3 2025, $5.1 million for Q2 2025, and $5.1 million during Q1 2025.